Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Conceptualisation of the characteristics of advanced practitioners in the medical radiation professions.

Journal of medical radiation sciences

Smith T, Harris J, Woznitza N, Maresse S, Sale C.
PMID: 26451243
J Med Radiat Sci. 2015 Sep;62(3):204-11. doi: 10.1002/jmrs.115. Epub 2015 Jun 27.

Professions grapple with defining advanced practice and the characteristics of advanced practitioners. In nursing and allied health, advanced practice has been defined as 'a state of professional maturity in which the individual demonstrates a level of integrated knowledge, skill...

Cite
Smith T, Harris J, Woznitza N, et al. Conceptualisation of the characteristics of advanced practitioners in the medical radiation professions. J Med Radiat Sci. 2015;62(3):204-11doi: 10.1002/jmrs.115.
Smith, T., Harris, J., Woznitza, N., Maresse, S., & Sale, C. (2015). Conceptualisation of the characteristics of advanced practitioners in the medical radiation professions. Journal of medical radiation sciences, 62(3), 204-11. https://doi.org/10.1002/jmrs.115
Smith, Tony, et al. "Conceptualisation of the characteristics of advanced practitioners in the medical radiation professions." Journal of medical radiation sciences vol. 62,3 (2015): 204-11. doi: https://doi.org/10.1002/jmrs.115
Smith T, Harris J, Woznitza N, Maresse S, Sale C. Conceptualisation of the characteristics of advanced practitioners in the medical radiation professions. J Med Radiat Sci. 2015 Sep;62(3):204-11. doi: 10.1002/jmrs.115. Epub 2015 Jun 27. PMID: 26451243; PMCID: PMC4592675.
Copy Download .nbib Format: NLM
Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.

EJNMMI research

Tegnebratt T, Ruge E, Bader S, Ishii N, Aida S, Yoshimura Y, Ooi CH, Lu L, Mitsios N, Meresse V, Mulder J, Pawlak M, Venturi M, Tessier J, Stone-Elander S.
PMID: 26116108
EJNMMI Res. 2014 Dec;4(1):34. doi: 10.1186/s13550-014-0034-6. Epub 2014 Sep 09.

BACKGROUND: Inhibition of mitogen-activated protein kinase (MEK, also known as MAPK2, MAPKK), a key molecule of the Ras/MAPK (mitogen-activated protein kinase) pathway, has shown promising effects on B-raf-mutated and some RAS (rat sarcoma)-activated tumors in clinical trials. The objective...

Cite
Tegnebratt T, Ruge E, Bader S, et al. Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches. EJNMMI Res. 2014;4(1):34doi: 10.1186/s13550-014-0034-6.
Tegnebratt, T., Ruge, E., Bader, S., Ishii, N., Aida, S., Yoshimura, Y., Ooi, C. H., Lu, L., Mitsios, N., Meresse, V., Mulder, J., Pawlak, M., Venturi, M., Tessier, J., & Stone-Elander, S. (2014). Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches. EJNMMI research, 4(1), 34. https://doi.org/10.1186/s13550-014-0034-6
Tegnebratt, Tetyana, et al. "Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches." EJNMMI research vol. 4,1 (2014): 34. doi: https://doi.org/10.1186/s13550-014-0034-6
Tegnebratt T, Ruge E, Bader S, Ishii N, Aida S, Yoshimura Y, Ooi CH, Lu L, Mitsios N, Meresse V, Mulder J, Pawlak M, Venturi M, Tessier J, Stone-Elander S. Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches. EJNMMI Res. 2014 Dec;4(1):34. doi: 10.1186/s13550-014-0034-6. Epub 2014 Sep 09. PMID: 26116108; PMCID: PMC4452660.
Copy Download .nbib Format: NLM
Pressure induces major changes in the nature of Americium's 5f electrons.

Physical review letters

Heathman S, Haire RG, Le Bihan T, Lindbaum A, Litfin K, Méresse Y, Libotte H.
PMID: 11005978
Phys Rev Lett. 2000 Oct 02;85(14):2961-4. doi: 10.1103/PhysRevLett.85.2961.

Americium occupies a pivotal position in the actinide series with regard to the behavior of 5f electrons. High-pressure techniques together with synchrotron radiation have been used to determine the structural behavior up to 100 GPa. We have resolved earlier...

Cite
Heathman S, Haire RG, Le Bihan T, et al. Pressure induces major changes in the nature of Americium's 5f electrons. Phys Rev Lett. 2000;85(14):2961-4doi: 10.1103/PhysRevLett.85.2961.
Heathman, S., Haire, R. G., Le Bihan T, Lindbaum, A., Litfin, K., Méresse, Y., & Libotte, H. (2000). Pressure induces major changes in the nature of Americium's 5f electrons. Physical review letters, 85(14), 2961-4. https://doi.org/10.1103/PhysRevLett.85.2961
Heathman, S, et al. "Pressure induces major changes in the nature of Americium's 5f electrons." Physical review letters vol. 85,14 (2000): 2961-4. doi: https://doi.org/10.1103/PhysRevLett.85.2961
Heathman S, Haire RG, Le Bihan T, Lindbaum A, Litfin K, Méresse Y, Libotte H. Pressure induces major changes in the nature of Americium's 5f electrons. Phys Rev Lett. 2000 Oct 02;85(14):2961-4. doi: 10.1103/PhysRevLett.85.2961. PMID: 11005978.
Copy Download .nbib Format: NLM
[18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models.

EJNMMI research

Tegnebratt T, Lu L, Lee L, Meresse V, Tessier J, Ishii N, Harada N, Pisa P, Stone-Elander S.
PMID: 24041012
EJNMMI Res. 2013 Sep 16;3(1):67. doi: 10.1186/2191-219X-3-67.

BACKGROUND: Positron emission tomography (PET) with [2-18 F]-2-fluoro-2-deoxy-D-glucose ([18 F]FDG-PET) was acquired at multiple time-points a) to monitor the early response to RO5126766 (CH5126766) in xenograft models b) to evaluate non-invasive small animal [18 F]FDG-PET imaging as a biomarker...

Cite
Tegnebratt T, Lu L, Lee L, et al. [18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models. EJNMMI Res. 2013;3(1):67doi: 10.1186/2191-219X-3-67.
Tegnebratt, T., Lu, L., Lee, L., Meresse, V., Tessier, J., Ishii, N., Harada, N., Pisa, P., & Stone-Elander, S. (2013). [18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models. EJNMMI research, 3(1), 67. https://doi.org/10.1186/2191-219X-3-67
Tegnebratt, Tetyana, et al. "[18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models." EJNMMI research vol. 3,1 (2013): 67. doi: https://doi.org/10.1186/2191-219X-3-67
Tegnebratt T, Lu L, Lee L, Meresse V, Tessier J, Ishii N, Harada N, Pisa P, Stone-Elander S. [18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models. EJNMMI Res. 2013 Sep 16;3(1):67. doi: 10.1186/2191-219X-3-67. PMID: 24041012; PMCID: PMC3848680.
Copy Download .nbib Format: NLM
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook.

Expert review of clinical immunology

Selvestrel D, Lucafò M, Pugnetti L, Pagarin S, Moressa V, Pastore S, Taddio A, Stocco G, Decorti G.
PMID: 34392756
Expert Rev Clin Immunol. 2021 Oct;17(10):1131-1142. doi: 10.1080/1744666X.2021.1968833. Epub 2021 Aug 19.

INTRODUCTION: Juvenile idiopathic arthritis (JIA) is a chronic disease characterized by persistent joint inflammation. JIA is the most common pediatric chronic rheumatic disease and no curative therapy is currently available. Methotrexate (MTX) is an important treatment for JIA even...

Cite
Selvestrel D, Lucafò M, Pugnetti L, et al. Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook. Expert Rev Clin Immunol. 2021;17(10):1131-1142doi: 10.1080/1744666X.2021.1968833.
Selvestrel, D., Lucafò, M., Pugnetti, L., Pagarin, S., Moressa, V., Pastore, S., Taddio, A., Stocco, G., & Decorti, G. (2021). Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook. Expert review of clinical immunology, 17(10), 1131-1142. https://doi.org/10.1080/1744666X.2021.1968833
Selvestrel, Davide, et al. "Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook." Expert review of clinical immunology vol. 17,10 (2021): 1131-1142. doi: https://doi.org/10.1080/1744666X.2021.1968833
Selvestrel D, Lucafò M, Pugnetti L, Pagarin S, Moressa V, Pastore S, Taddio A, Stocco G, Decorti G. Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook. Expert Rev Clin Immunol. 2021 Oct;17(10):1131-1142. doi: 10.1080/1744666X.2021.1968833. Epub 2021 Aug 19. PMID: 34392756.
Copy Download .nbib Format: NLM
The Salmonella effector SifA initiates a kinesin-1 and kinesin-3 recruitment process mirroring that mediated by Arl8a and Arl8b.

Journal of cell science

Fang Z, Fallet M, Moest T, Gorvel JP, Méresse S.
PMID: 34878110
J Cell Sci. 2022 Dec 01;135(1). doi: 10.1242/jcs.259183. Epub 2022 Jan 10.

When intracellular, pathogenic Salmonella reside in a membrane compartment composed of interconnected vacuoles and tubules, the formation of which depends on the translocation of bacterial effectors into the host cell. Cytoskeletons and their molecular motors are prime targets for...

Cite
Fang Z, Fallet M, Moest T, et al. The Salmonella effector SifA initiates a kinesin-1 and kinesin-3 recruitment process mirroring that mediated by Arl8a and Arl8b. J Cell Sci. 2022;135(1)doi: 10.1242/jcs.259183.
Fang, Z., Fallet, M., Moest, T., Gorvel, J. P., & Méresse, S. (2022). The Salmonella effector SifA initiates a kinesin-1 and kinesin-3 recruitment process mirroring that mediated by Arl8a and Arl8b. Journal of cell science, 135(1), . https://doi.org/10.1242/jcs.259183
Fang, Ziyan, et al. "The Salmonella effector SifA initiates a kinesin-1 and kinesin-3 recruitment process mirroring that mediated by Arl8a and Arl8b." Journal of cell science vol. 135,1 (2022). doi: https://doi.org/10.1242/jcs.259183
Fang Z, Fallet M, Moest T, Gorvel JP, Méresse S. The Salmonella effector SifA initiates a kinesin-1 and kinesin-3 recruitment process mirroring that mediated by Arl8a and Arl8b. J Cell Sci. 2022 Dec 01;135(1). doi: 10.1242/jcs.259183. Epub 2022 Jan 10. PMID: 34878110.
Copy Download .nbib Format: NLM
Severe SARS-CoV-2 patients develop a higher specific T-cell response.

Clinical & translational immunology

Demaret J, Lefèvre G, Vuotto F, Trauet J, Duhamel A, Labreuche J, Varlet P, Dendooven A, Stabler S, Gachet B, Bauer J, Prevost B, Bocket L, Alidjinou EK, Lambert M, Yelnik C, Meresse B, Dubuquoy L, Launay D, Dubucquoi S, Montaigne D, Woitrain E, Maggiotto F, Bou Saleh M, Top I, Elsermans V, Jeanpierre E, Dupont A, Susen S, Brousseau T, Poissy J, Faure K, Labalette M.
PMID: 33376594
Clin Transl Immunology. 2020 Dec 23;9(12):e1217. doi: 10.1002/cti2.1217. eCollection 2020.

OBJECTIVES: Assessment of the adaptive immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for studying long-term immunity and vaccine strategies. We quantified IFNγ-secreting T cells reactive against the main viral SARS-CoV-2 antigens using a standardised...

Cite
Demaret J, Lefèvre G, Vuotto F, et al. Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology. 2020;9(12):e1217doi: 10.1002/cti2.1217.
Demaret, J., Lefèvre, G., Vuotto, F., Trauet, J., Duhamel, A., Labreuche, J., Varlet, P., Dendooven, A., Stabler, S., Gachet, B., Bauer, J., Prevost, B., Bocket, L., Alidjinou, E. K., Lambert, M., Yelnik, C., Meresse, B., Dubuquoy, L., Launay, D., Dubucquoi, S., Montaigne, D., Woitrain, E., Maggiotto, F., Bou Saleh, M., Top, I., Elsermans, V., Jeanpierre, E., Dupont, A., Susen, S., Brousseau, T., Poissy, J., Faure, K., Labalette, M. (2020). Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clinical & translational immunology, 9(12), e1217. https://doi.org/10.1002/cti2.1217
Demaret, Julie, et al. "Severe SARS-CoV-2 patients develop a higher specific T-cell response." Clinical & translational immunology vol. 9,12 (2020): e1217. doi: https://doi.org/10.1002/cti2.1217
Demaret J, Lefèvre G, Vuotto F, Trauet J, Duhamel A, Labreuche J, Varlet P, Dendooven A, Stabler S, Gachet B, Bauer J, Prevost B, Bocket L, Alidjinou EK, Lambert M, Yelnik C, Meresse B, Dubuquoy L, Launay D, Dubucquoi S, Montaigne D, Woitrain E, Maggiotto F, Bou Saleh M, Top I, Elsermans V, Jeanpierre E, Dupont A, Susen S, Brousseau T, Poissy J, Faure K, Labalette M. Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology. 2020 Dec 23;9(12):e1217. doi: 10.1002/cti2.1217. eCollection 2020. PMID: 33376594; PMCID: PMC7757425.
Copy Download .nbib Format: NLM
Molecular Characterization of SehB, a Type II Antitoxin of .

Frontiers in microbiology

Chimal-Cázares F, Hernández-Martínez G, Pacheco S, Ares MA, Soria-Bustos J, Sánchez-Gutiérrez M, Izquierdo-Vega JA, Ibarra JA, González-Y-Merchand JA, Gorvel JP, Méresse S, De la Cruz MA.
PMID: 32328049
Front Microbiol. 2020 Apr 09;11:614. doi: 10.3389/fmicb.2020.00614. eCollection 2020.

No abstract available.

Cite
Chimal-Cázares F, Hernández-Martínez G, Pacheco S, et al. Molecular Characterization of SehB, a Type II Antitoxin of . Front Microbiol. 2020;11:614doi: 10.3389/fmicb.2020.00614.
Chimal-Cázares, F., Hernández-Martínez, G., Pacheco, S., Ares, M. A., Soria-Bustos, J., Sánchez-Gutiérrez, M., Izquierdo-Vega, J. A., Ibarra, J. A., González-Y-Merchand, J. A., Gorvel, J. P., Méresse, S., & De la Cruz, M. A. (2020). Molecular Characterization of SehB, a Type II Antitoxin of . Frontiers in microbiology, 11614. https://doi.org/10.3389/fmicb.2020.00614
Chimal-Cázares, Fernando, et al. "Molecular Characterization of SehB, a Type II Antitoxin of ." Frontiers in microbiology vol. 11 (2020): 614. doi: https://doi.org/10.3389/fmicb.2020.00614
Chimal-Cázares F, Hernández-Martínez G, Pacheco S, Ares MA, Soria-Bustos J, Sánchez-Gutiérrez M, Izquierdo-Vega JA, Ibarra JA, González-Y-Merchand JA, Gorvel JP, Méresse S, De la Cruz MA. Molecular Characterization of SehB, a Type II Antitoxin of . Front Microbiol. 2020 Apr 09;11:614. doi: 10.3389/fmicb.2020.00614. eCollection 2020. PMID: 32328049; PMCID: PMC7160566.
Copy Download .nbib Format: NLM
Evaluation of Antihyperglycemic Effect of Extract of .

Diabetes, metabolic syndrome and obesity : targets and therapy

Woldekidan S, Mulu A, Ergetie W, Teka F, Meressa A, Tadele A, Abebe A, Gemechu W, Gemeda N, Ashebir R, Sileshi M, Tolcha Y.
PMID: 33488106
Diabetes Metab Syndr Obes. 2021 Jan 15;14:185-192. doi: 10.2147/DMSO.S266794. eCollection 2021.

BACKGROUND: Diabetes is a serious metabolic disorder with complications that result in significant morbidity and mortality. Current drugs used for diabetes therapy are not free from side effects and do not restore normal glucose homeostasis. Therefore, the purpose of...

Cite
Woldekidan S, Mulu A, Ergetie W, et al. Evaluation of Antihyperglycemic Effect of Extract of . Diabetes Metab Syndr Obes. 2021;14:185-192doi: 10.2147/DMSO.S266794.
Woldekidan, S., Mulu, A., Ergetie, W., Teka, F., Meressa, A., Tadele, A., Abebe, A., Gemechu, W., Gemeda, N., Ashebir, R., Sileshi, M., & Tolcha, Y. (2021). Evaluation of Antihyperglycemic Effect of Extract of . Diabetes, metabolic syndrome and obesity : targets and therapy, 14185-192. https://doi.org/10.2147/DMSO.S266794
Woldekidan, Samuel, et al. "Evaluation of Antihyperglycemic Effect of Extract of ." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 14 (2021): 185-192. doi: https://doi.org/10.2147/DMSO.S266794
Woldekidan S, Mulu A, Ergetie W, Teka F, Meressa A, Tadele A, Abebe A, Gemechu W, Gemeda N, Ashebir R, Sileshi M, Tolcha Y. Evaluation of Antihyperglycemic Effect of Extract of . Diabetes Metab Syndr Obes. 2021 Jan 15;14:185-192. doi: 10.2147/DMSO.S266794. eCollection 2021. PMID: 33488106; PMCID: PMC7815076.
Copy Download .nbib Format: NLM
Single-cell analysis: Understanding infected cell heterogeneity.

Virulence

Alberdi L, Méresse S.
PMID: 27786599
Virulence. 2017 Aug 18;8(6):605-606. doi: 10.1080/21505594.2016.1253659. Epub 2016 Oct 27.

No abstract available.

Cite
Alberdi L, Méresse S. Single-cell analysis: Understanding infected cell heterogeneity. Virulence. 2016;8(6):605-606doi: 10.1080/21505594.2016.1253659.
Alberdi, L., & Méresse, S. (2017). Single-cell analysis: Understanding infected cell heterogeneity. Virulence, 8(6), 605-606. https://doi.org/10.1080/21505594.2016.1253659
Alberdi, Lucrecia, and Méresse, Stéphane. "Single-cell analysis: Understanding infected cell heterogeneity." Virulence vol. 8,6 (2017): 605-606. doi: https://doi.org/10.1080/21505594.2016.1253659
Alberdi L, Méresse S. Single-cell analysis: Understanding infected cell heterogeneity. Virulence. 2017 Aug 18;8(6):605-606. doi: 10.1080/21505594.2016.1253659. Epub 2016 Oct 27. PMID: 27786599; PMCID: PMC5626242.
Copy Download .nbib Format: NLM
[Population as a system: a definition of the object of demographic research].

Studia demograficzne

Mereste U.
PMID: 12263571
Studia Demogr. 1977;(47):87-101.

No abstract available.

Cite
Mereste U. Ludosc jako system: okreslenie przedmiotu badan demograficznych [Population as a system: a definition of the object of demographic research]. Studia Demogr. 1977;(47):87-101
Mereste, U. (1977). Ludosc jako system: okreslenie przedmiotu badan demograficznych [Population as a system: a definition of the object of demographic research]. Studia demograficzne, (47), 87-101.
Mereste, U. "Ludosc jako system: okreslenie przedmiotu badan demograficznych" [Population as a system: a definition of the object of demographic research]. Studia demograficzne vol. ,47 (1977): 87-101.
Mereste U. Ludosc jako system: okreslenie przedmiotu badan demograficznych [Population as a system: a definition of the object of demographic research]. Studia Demogr. 1977;(47):87-101. Polish. PMID: 12263571.
Copy Download .nbib Format: NLM
Novel ensembles of COPRAS multi-criteria decision-making with logistic regression, boosted regression tree, and random forest for spatial prediction of gully erosion susceptibility.

The Science of the total environment

Arabameri A, Yamani M, Pradhan B, Melesse A, Shirani K, Tien Bui D.
PMID: 31255826
Sci Total Environ. 2019 Oct 20;688:903-916. doi: 10.1016/j.scitotenv.2019.06.205. Epub 2019 Jun 20.

Gully erosion is considered as a severe environmental problem in many areas of the world which causes huge damages to agricultural lands and infrastructures (i.e. roads, buildings, and bridges); however, gully erosion modeling and prediction with high accuracy are...

Cite
Arabameri A, Yamani M, Pradhan B, et al. Novel ensembles of COPRAS multi-criteria decision-making with logistic regression, boosted regression tree, and random forest for spatial prediction of gully erosion susceptibility. Sci Total Environ. 2019;688:903-916doi: 10.1016/j.scitotenv.2019.06.205.
Arabameri, A., Yamani, M., Pradhan, B., Melesse, A., Shirani, K., & Tien Bui, D. (2019). Novel ensembles of COPRAS multi-criteria decision-making with logistic regression, boosted regression tree, and random forest for spatial prediction of gully erosion susceptibility. The Science of the total environment, 688903-916. https://doi.org/10.1016/j.scitotenv.2019.06.205
Arabameri, Alireza, et al. "Novel ensembles of COPRAS multi-criteria decision-making with logistic regression, boosted regression tree, and random forest for spatial prediction of gully erosion susceptibility." The Science of the total environment vol. 688 (2019): 903-916. doi: https://doi.org/10.1016/j.scitotenv.2019.06.205
Arabameri A, Yamani M, Pradhan B, Melesse A, Shirani K, Tien Bui D. Novel ensembles of COPRAS multi-criteria decision-making with logistic regression, boosted regression tree, and random forest for spatial prediction of gully erosion susceptibility. Sci Total Environ. 2019 Oct 20;688:903-916. doi: 10.1016/j.scitotenv.2019.06.205. Epub 2019 Jun 20. PMID: 31255826.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries